Drug intelligence / Profile preview

Yinma Jiedu

Development stage
Unknown
Lead developer
Guangdong Provincial Hospital of Traditional Chinese Medicine
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration
Oral
01

Overview

Yinma Jiedu is a Traditional Chinese Medicine (TCM) granule formulation developed by the Guangdong Provincial Hospital of Chinese Medicine. It is primarily investigated as an adjunctive therapy to standard antibiotics for the treatment of community-acquired pneumonia (CAP). The formula is designed based on TCM principles to clear heat, detoxify, and ventilate the lungs, aiming to mitigate the inflammatory response and improve clinical recovery in patients with pulmonary infections. It is currently being evaluated in multicenter, randomized, double-blind, placebo-controlled clinical trials to establish its efficacy and safety profile in hospitalized patients.

Brand names
Yinma Jiedu
Other names
Yinma Jiedu granules银马解毒颗粒
02

Targets

HMGB1 (High mobility group protein B1)NLRP3 (Nod-like receptor family pyrin domain-containing protein 3)HIF-1 (Hypoxia-inducible factor 1)HSD11B2 (11β-HSD2)

Beyond the preview

Go deeper on Yinma Jiedu.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Yinma Jiedu.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call